Purpose: Studies on the expression of epithelial membrane proteins (EMPs) in breast cancer have been rare and limited. In the present study, we aimed to evaluate the expression of EMP1, EMP2, and EMP3 in invasive ductal carcinoma (IDC) of the breast, and investigate their clinical implications. Methods: In total, 418 IDC cases were collected, and specimens were used to construct a tissue microarray. Immunohistochemical staining of EMP1, EMP2, and EMP3 was performed and the results were analyzed in combination with the clinical data. Results: EMP1 was expressed in > 90% of all IDC subtypes. A decreased expression of EMP2 and EMP3 was observed in triple-negative breast cancer. EMP3 expression was independently associated with human epidermal growth factor receptor 2 (HER2) positivity. HER2-negative cases exhibited a decreased EMP2 expression along with a higher histological grade and an increased proliferative index. No significant difference was found in the overall survival or disease-free survival based on the EMP expression. In HER2-negative breast cancer, EMP2 expression inversely correlated with the histological grade and proliferative index. Conclusion: EMP2 may be involved in the early stage of tumor development in hormone-positive breast cancer.
|Number of pages||13|
|Journal||Journal of Breast Cancer|
|Publication status||Published - 2020 Aug|
Bibliographical noteFunding Information:
This study was supported by a faculty research grant from the Yonsei University College of Medicine (6-2018-0080).
© 2020 Korean Breast Cancer Society.
All Science Journal Classification (ASJC) codes
- Cancer Research